Product Benefits Legend Sampling to Physicians and Alternatives to Sampling Controlled Substance Sampling to Physicians and Alternatives to Sampling Wholesale Distribution Pedigree Requirements Mid-level Practitioner Sampling Authority Porzio Compliance Digest Porzio Licensing Services Porzio AggregateSpendID℠ Porzio Compliance Modules Porzio Significant Loss Threshold Assurance ePorzio Porzio Other Services Our People Recent Articles Events News Careers Home Products & Services About Us Contact Us Subscriber Login GoToMeeting Blog
About Us Our People Recent Articles Events News Careers   About Us > Recent Articles Recent Articles 05/01/2010   Taking Stock of the Marketing Retrictions and Prohibitions of Academic Medical Centers FDLI Update by D. Jeffrey Campbell and Christine N. Bradshaw       04/01/2010   Thriving Through Turmoil: Managing Sales and Marketing Regulation of the Medical Device Industry FDLI Update by D. Jeffrey Campbell and Jennifer A. Sanfilippo       02/01/2010   The Perfect Storm: Weathering the Convergence of Federal, State and Industry Regulations Impacting Pharmaceutical Sales and Marketing Representatives FDLI Update by D. Jeffrey Campbell and Sarina D. Rivera       09/01/2009   Navigating Loss Reporting: How to Meet FDA and State Reporting Requirements Thought Leadership Sales and Marketing Compliance by Anne E. Wagstaff, John E. Niznik and Rhonda Sobral O'Toole       09/01/2009   What's All the Commotion Over Aggregate Spend? Thought Leadership Sales and Marketing Compliance by John Patrick Oroho and Christine N. Bradshaw       06/01/2009   Court Prescribes No Overtime for Pharmaceutical Sales Rep New Jersey Defense Quarterly by Kerri A. Wright       05/28/2009   Sales Rep Nightmares: Emerging Issues in Marketing Compliance FDLI Update by John Patrick Oroho and Christine N. Bradshaw       03/09/2009   Over-the-Counter and Prescription Drug Manufacturers are Granted a One Year Reprieve from the Burdensome Requirements of the Consumer Product Safety Improvement Act Porzio Pharmaceutical Alert by Frank Fazio and Anne E. Wagstaff       02/01/2009   The End or Just the Beginning? Exploring Federal Preemption of State and Distribution Laws Pharmaceutical Commerce by Sarina D. Rivera, Jennifer A. Sanfilippo and Kiaema R. Reid       09/11/2009   DDMAC Reasserts Its Oversight of Promotion Directed Not Only to Physicians, But Also to P&T Committees Porzio Pharmaceutical Alert by Linda Pissott Reig, Jennifer A. Romanski and Sarina D. Rivera       08/27/2008   Navigating Through the Disparities of State Marketing Tracking and Disclosure Laws Thought Leadership Sales and Marketing Compliance by Garineh S. Dovletian and Christopher R. Corallo       06/18/2007   Newly Enacted Nevada Statute Requires Adoption of a "Marketing Code of Conduct." Porzio Pharmaceutical Alert by Linda Pissott Reig, Christopher R. Corallo and John Patrick Oroho       06/01/2007   State Marketing Disclosure Laws - The Unintended Consequences FDLI Update by Sarina D. Rivera       05/30/2007   Online DTC: Marketing Push Meets Consumer Pull Pharmaceutical Commerce by John Patrick Oroho       05/21/2007   Can Prosecutors Use Data from Sample Distribution as Evidence of Off-Label Promotion? Thought Leadership Sales and Marketing Compliance by John Patrick Oroho and Scott S. Liebman
<< Back     ©  Porzio Pharmaceutical Services, LLC